Use of Rohitaka Moola Kalka and Amalaki beeja kalka in the management of Shweta Pradara (Leucorrhoea)

Phase 3

Not yet recruiting

• Conditions: Other specified noninflammatory disorders of vagina. Ayurveda Condition: SOMAROGAH/SVETAPRADARAH,

• Registration Number: CTRI/2025/05/086583
• Lead Sponsor: Dr Ayushi Baranwal

Brief Summary

The condition characterized with excessive secretion. Shweta pradara is not a disease but a symptom of various underlying health conditions. However, depending on the etiopathogenesis Shweta Pradara occurs due to vitiation of kapha which gets vitiated due to its own vitiating factor which further influences rasa dhatu along with other causative factors.There are several drugs for Shweta Pradara but here I have chosen comparative study between two single drugs i.e. Amalaki beeja kalka  with madhu and sharkara and Rohitaka Moola Kalka with water which not only treats symptoms but also does samprapti bhanga.

Therefore I have selected 60 patients aged between 18-45 years, patients should be selected on the basis of inclusion and exclusion criteria. The trial will be of 3 consecutive months and follow up will be done after 3 days then after each months. Cured after 3 months patient gets 80-100percent  relief from sign and symptoms.

Detailed Description

Not available

Study Timeline

• Study Start: 2025-02-06

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

Women in the age group of 18-45 years Patients complaining of white discharge per vaginum as a cardinal or associated symptom Patients willing for trial and ready to give written consent.

Exclusion Criteria

Patients suffering from STD’s Any other systemic disorder like Diabetes Mellitus Patients having any other gynecological problems like prolapse, fibroid, etc Pregnant women with profuse white discharge.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement in amount of vaginal discharge	3 months | The trial drug will be given for 3 months with anupana and follow up will be done after cessation of medicine in 4 month

Secondary Outcome Measures

Name	Time	Method
Relief in Itching Lower backache and tenderness Per vagina	After analyzing all the parameters the result will

Trial Locations

Locations (1)

Vaidya Yagya Dutt Sharma Ayurved Mahavidyalaya Khurja Bulandshahr; 🇮🇳 Bulandshahar, UTTAR PRADESH, India

Vaidya Yagya Dutt Sharma Ayurved Mahavidyalaya Khurja Bulandshahr

🇮🇳Bulandshahar, UTTAR PRADESH, India

Dr Ayushi Baranwal

Principal investigator

9535541671

ayushibaranwal12@gmail.com